“An Open-Label, Pilot Study to Evaluate the Benefits of Using Lyophilized Human Milk-Derived Nutritional Product (NeoLact 70 – 1.55 G) As an Immune-Nutritional Supplement in Premature Infants Discharged from NICU”. 2021. Indian Journal of Child Health 8 (12): 404-7. https://doi.org/10.32677/ijch.v8i12.3213.